Nike stock (NKE) climbs after CEO Elliott Hill buys $1 million in shares
2 January 2026
2 mins read

Nike stock (NKE) climbs after CEO Elliott Hill buys $1 million in shares

NEW YORK, January 1, 2026, 19:55 ET — Market closed

  • Nike ended the last U.S. trading session up 4.2% at $63.71.
  • A regulatory filing showed CEO Elliott Hill bought 16,388 shares for about $1 million.
  • A separate filing showed Chairman Emeritus Phil Knight received 4.5 million convertible shares via a distribution from an affiliated entity.

Nike shares ended the last U.S. trading session up 4.2% at $63.71, after a regulatory filing showed Chief Executive Elliott Hill bought about $1 million worth of stock.

Insider buying — when executives use personal funds to buy shares — often draws attention because it can signal confidence at a moment when investors are debating whether a turnaround is taking hold.

That matters now for Nike because the stock has been under pressure and year-end trading can exaggerate moves, with investors repositioning for the start of the new year. A Reuters market report noted thin trading ahead of the New Year’s Day holiday, and “it’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity. 1

The stock traded between $61.96 and $64.19 in the last session, with about 35.5 million shares changing hands, according to market data.

In a Form 4 filing with the U.S. Securities and Exchange Commission, Hill disclosed he bought 16,388 Nike Class B shares on Dec. 29 at a weighted average price of $61.10, lifting his direct holdings to 241,587 shares. 2

A separate Form 4 showed Chairman Emeritus Phil Knight received 4.5 million shares of Nike Class A common stock that is convertible into Class B shares, via a private pro rata distribution from Swoosh, LLC, an affiliated entity. 3

Form 4 is the disclosure insiders file after trading in their company’s stock, giving investors a real-time look at who is buying or selling. Those disclosures can sway sentiment, even though insider buying alone does not determine a company’s fundamentals.

Investors have been focused on the pace of Nike’s recovery as it works through pressure on gross margins and weaker demand in China, while trying to stabilize the business in North America and refresh marketing, according to a Reuters “BUZZ” report on the move. 4

Before the next session, traders will be watching whether Nike can hold the bulk of Wednesday’s gains when U.S. markets reopen on Friday, Jan. 2, after the New Year’s Day holiday. The $64 area, near the prior session’s highs, is an early level on many screens.

Nike has not yet announced the date for its next earnings report. MarketBeat estimates the next report for March 19, based on past reporting patterns, and investors are expected to press for updates on margins, inventory and the China demand trend. 5

Macro data will also be in focus as 2026 gets underway, including the U.S. Employment Situation report for December 2025, scheduled for Jan. 9, which can shift expectations for consumer spending and interest rates. 6

Nike’s shares remain well below their 52-week high of $82.44 and above the 52-week low of $52.28, according to the company’s investor relations stock information page, leaving investors split between “bottoming” hopes and demands for clearer evidence that the turnaround is translating into earnings power. 7

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
SoFi stock price today: SOFI closes lower ahead of 2026 as traders brace for rates and January data
Previous Story

SoFi stock price today: SOFI closes lower ahead of 2026 as traders brace for rates and January data

Pfizer stock today: PFE slips as report flags 2026 U.S. drug price hikes
Next Story

Pfizer stock today: PFE slips as report flags 2026 U.S. drug price hikes

Go toTop